Pages that link to "Q36231857"
Jump to navigation
Jump to search
The following pages link to Engineered humanized dimeric forms of IgG are more effective antibodies (Q36231857):
Displaying 12 items.
- Improving the efficacy of antibody-based cancer therapies (Q28208361) (← links)
- A fusion protein composed of receptor binding domain of vascular endothelial growth factor-A and constant region fragment of antibody: angiogenesis antagonistic activity (Q34836822) (← links)
- Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells (Q36659424) (← links)
- Antibody-based therapies as anti-infective agents (Q39216839) (← links)
- Design, Construction, and In Vitro Analyses of Multivalent Antibodies (Q40650481) (← links)
- Monoclonal antibodies: innovations in diagnosis and therapy (Q41051846) (← links)
- Hematology: The Biological Therapy of Acute and Chronic Leukemia (Q41552414) (← links)
- Recombinant polymeric IgG: an approach to engineering more potent antibodies. (Q46027838) (← links)
- IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. (Q52876790) (← links)
- Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants (Q72035891) (← links)
- [Recombinant immunoglobulins] (Q72265732) (← links)
- Site-specific conjugation on serine right-arrow cysteine variant monoclonal antibodies (Q73954600) (← links)